ATE178074T1 - Proinsulin-peptid-verbindungen für den nachweis und die behandlung von typ-i-diabetes - Google Patents

Proinsulin-peptid-verbindungen für den nachweis und die behandlung von typ-i-diabetes

Info

Publication number
ATE178074T1
ATE178074T1 AT95926642T AT95926642T ATE178074T1 AT E178074 T1 ATE178074 T1 AT E178074T1 AT 95926642 T AT95926642 T AT 95926642T AT 95926642 T AT95926642 T AT 95926642T AT E178074 T1 ATE178074 T1 AT E178074T1
Authority
AT
Austria
Prior art keywords
proinsulin
type
diabetes
peptide compounds
proinsulin peptide
Prior art date
Application number
AT95926642T
Other languages
English (en)
Inventor
William F Hickey
Ann C Griffin
Original Assignee
Dartmouth College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26955374&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE178074(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dartmouth College filed Critical Dartmouth College
Application granted granted Critical
Publication of ATE178074T1 publication Critical patent/ATE178074T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/62—Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Microbiology (AREA)
  • Emergency Medicine (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
AT95926642T 1994-07-08 1995-07-07 Proinsulin-peptid-verbindungen für den nachweis und die behandlung von typ-i-diabetes ATE178074T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27222094A 1994-07-08 1994-07-08
US47270495A 1995-06-06 1995-06-06

Publications (1)

Publication Number Publication Date
ATE178074T1 true ATE178074T1 (de) 1999-04-15

Family

ID=26955374

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95926642T ATE178074T1 (de) 1994-07-08 1995-07-07 Proinsulin-peptid-verbindungen für den nachweis und die behandlung von typ-i-diabetes

Country Status (12)

Country Link
US (1) US20030220229A1 (de)
EP (1) EP0788512B1 (de)
JP (1) JPH10505821A (de)
CN (1) CN1157621A (de)
AT (1) ATE178074T1 (de)
AU (1) AU3094795A (de)
CA (1) CA2194548A1 (de)
DE (1) DE69508605T2 (de)
DK (1) DK0788512T3 (de)
ES (1) ES2130629T3 (de)
MX (1) MX9700198A (de)
WO (1) WO1996001846A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2289751T3 (es) 1995-02-20 2008-02-01 The Walter And Eliza Hall Institute Of Medical Research Moleculas inmunorreactivas e inmunoterapeuticas que interaccionan en sujetos con diabetes mellitus insulinodependientes (dmid).
SE520392C2 (sv) 1996-09-27 2003-07-01 Creative Peptides Sweden Ab C Specifika peptider för behandling av diabetes mellitus
AUPO269996A0 (en) * 1996-10-01 1996-10-24 Walter And Eliza Hall Institute Of Medical Research, The A method of prophylaxis and treatment
US7509406B2 (en) * 2004-09-30 2009-03-24 Microsoft Corporation Managing terminal services accounts and sessions for online utilization of a hosted application
ES2331342B1 (es) * 2006-05-22 2010-10-13 Consejo Superior Investg.Cientificas Uso de la proinsulina para la elaboracion de una composicion farmaceutica neuroprotectora, composicion terapeutica que la contiene y sus aplicaciones.
CN103630692B (zh) * 2013-06-02 2015-05-06 马鞍山国声生物技术有限公司 快速检测尿液c肽的胶体金免疫层析试剂盒及其检测方法
KR102393711B1 (ko) * 2013-10-17 2022-05-04 더 제너럴 하스피탈 코포레이션 자가면역 질환의 치료에 반응하는 대상체의 식별 방법 및 그의 치료를 위한 조성물
GB2559499A (en) * 2014-02-25 2018-08-08 Orban Tihamer Immunomodulatory therapy for type 1 diabetes mellitus autoimmunity
GB2523399B (en) 2014-02-25 2019-03-13 Orban Tihamer A composition comprising ten overlapping peptide fragments of the entire preproinsulin sequence

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5210872B2 (de) * 1973-07-14 1977-03-26
US4308181A (en) * 1980-12-08 1981-12-29 American Home Products Corporation Polypeptide compositions
US4652548A (en) * 1981-08-27 1987-03-24 Eli Lilly And Company Pharmaceutical formulations comprising human insulin, human C-peptide, and human proinsulin
US5114844A (en) * 1989-03-14 1992-05-19 Yeda Research And Development Co., Ltd. Diagnosis and treatment of insulin dependent diabetes mellitus
NL9001083A (nl) * 1990-05-04 1991-12-02 Rijksuniversiteit Beta-cel antigeen.
DE69122761T2 (de) * 1990-08-17 1997-03-13 Univ Florida Verfahren und komposition zum frühnachweiss und behandlung insulinabhängiger diabetes

Also Published As

Publication number Publication date
DE69508605T2 (de) 1999-07-22
MX9700198A (es) 1997-04-30
AU3094795A (en) 1996-02-09
DE69508605D1 (de) 1999-04-29
CN1157621A (zh) 1997-08-20
CA2194548A1 (en) 1996-01-25
DK0788512T3 (da) 1999-10-11
US20030220229A1 (en) 2003-11-27
ES2130629T3 (es) 1999-07-01
EP0788512B1 (de) 1999-03-24
JPH10505821A (ja) 1998-06-09
WO1996001846A1 (en) 1996-01-25
EP0788512A1 (de) 1997-08-13

Similar Documents

Publication Publication Date Title
YU18799A (sh) Monociklični l-nukleozidi, njihovi analozi i njihova upotreba
EP0671920A4 (de) Ein anti-idiotypischer antikörper und seine verwendung in der diagnose und therapie von hiv-verwandten krankheiten.
ATE32728T1 (de) Modifizierte protease-inhibitoren, verfahren zu ihrer herstellung und daraus bereitete pharmazeutische mittel.
DE3483085D1 (de) Desulfatohirudine, verfahren zu ihrer herstellung und pharmazeutische mittel.
TR199901696T2 (xx) Monoklonal veya poliklonal antikorlara ili�kin sabit liyofillenmi� farmakolojik terkipler.
TR199900431T2 (xx) �kame edilmi� siklik amin metaloproteaz inhibit�rleri
DK0643726T3 (da) Peptider af humant p53-protein til anvendelse i sammensætninger, som inducerer humant T-celle-respons, og humane p53-protei
ATE155888T1 (de) Zell-test für alzheimersche krankheit
ATE69239T1 (de) Oligopeptidylnitrilderivate, diese enthaltende mittel, verfahren zu ihrer herstellung und ihre verwendung.
ATE45153T1 (de) Benzisoselenazolthione, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische produkte.
ATE178074T1 (de) Proinsulin-peptid-verbindungen für den nachweis und die behandlung von typ-i-diabetes
DE69510336T2 (de) Verfahren zur diagnose von praeklampsie
ATE244299T1 (de) Test und behandlung von demyelinierenden krankheiten wie multiple sklerosis
MX9704738A (es) Analogos de peptido p277 y composiciones farmaceuticas que los contienen, metodo de diagnostico de diabetes mellitus dependiente de la insulina y uso de los mismos.
TR199800521T1 (xx) Se�imli beta3 adrenerjik agonistler.
DK0568554T3 (da) Fremgangsmåde til påvisning af anti-RNA-antistoffer
DE59508137D1 (de) Spezifische bindungssubstanzen für antikörper und deren verwendung für immunoassays oder vakzine
TR200504091T2 (tr) (7alfa,17alfa)-17-hidroksi-7-metil-19-nor-17-pregn-5(10)-en 20-in-3-on içeren yüksek saflıkta bileşim.
DK0764273T3 (da) Alfa B crystallin til anvendelse i diagnose og terapi af autoimmune sygdomme, især multipel sklerose
FI971427A (fi) Peptidit ja niitä sisältävät farmaseuttiset koostumukset
WO1996001846B1 (en) Proinsulin peptide compounds for detecting and treating type i diabetes
DE69532965D1 (de) Gegebenenfalls durch tc oder re radioaktiv markierte n3s2-chelate, geeignet für diagnostische oder therapeutische anwendungen
DK0972032T3 (da) Peptider til behandling af systemisk lupus erythematosus
ATE317021T1 (de) Antisense modulierung von lfa-3
DE69623325D1 (de) 4-hydroxycoumarin-3-carboxamide für die behandlung von nicht-insulin-abhängigen diabetes mellitus

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee
RZN Patent revoked